KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Candida glabrata (patient isolate)

• Candida glabrata
• Candida glabrata (00-547)
• Candida glabrata (1997)
• Candida glabrata (1998)
• Candida glabrata (1999)
• Candida glabrata (2002)
• Candida glabrata (2003)
• Candida glabrata (2004)
• Candida glabrata (24h)
• Candida glabrata (25℃)
• Candida glabrata (32930)
• Candida glabrata (33609)
• Candida glabrata (33616)
• Candida glabrata (34341)
• Candida glabrata (35315)
• Candida glabrata (37661)
• Candida glabrata (37℃)
• Candida glabrata (4690 + Japan)
• Candida glabrata (4707 + USA)
• Candida glabrata (4708 + USA)
• Candida glabrata (4720 + USA)
• Candida glabrata (48h)
• Candida glabrata (513)
• Candida glabrata (5376)
• Candida glabrata (5592)
• Candida glabrata (570)
• Candida glabrata (ATCC 10231)
• Candida glabrata (ATCC 2001)
• Candida glabrata (ATCC 36583)
• Candida glabrata (ATCC 60406)
• Candida glabrata (ATCC 90030)
• Candida glabrata (ATCC 90525)
• Candida glabrata (B115)
• Candida glabrata (B1226)
• Candida glabrata (B240)
• Candida glabrata (B532)
• Candida glabrata (B869)
• Candida glabrata (CBS 138)
• Candida glabrata (clinical isolate)
• Candida glabrata (CMAM 0592)
• Candida glabrata (CMAM 0594)
• Candida glabrata (CMAM 0597 + fluconazole-resistant)
• Candida glabrata (esophageal candidiasis isolate)
• Candida glabrata (fluconazole-resistant)
• Candida glabrata (fluconazole-susceptible)
• Candida glabrata (H16)
• Candida glabrata (H30)
• Candida glabrata (H36)
• Candida glabrata (HV91)
• Candida glabrata (HV94)
• Candida glabrata (IFM 5768)
• Candida glabrata (IFM 5799)
• Candida glabrata (IFO 0622)
• Candida glabrata (invasive candidiasis isolate)
• Candida glabrata (Israel)
• Candida glabrata (KCCM 50044)
• Candida glabrata (ketoconazole-resistant)
• Candida glabrata (Ketoconazole-susceptible)
• Candida glabrata (method : M27-A2-AM3 + 24h)
• Candida glabrata (method : M27-A2-AM3 + 48h)
• Candida glabrata (method : SYO + 24h)
• Candida glabrata (method : SYO + 48h)
• Candida glabrata (MY1381)
• Candida glabrata (NBRC 0622)
• Candida glabrata (patient isolate)
• Candida glabrata (T51916)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8